Home/Pipeline/Eplontersen

Eplontersen

ATTR Polyneuropathy

Phase III / MarketedActive/MarketedN/A

Key Facts

Indication
ATTR Polyneuropathy
Phase
Phase III / Marketed
Status
Active/Marketed
Company

About AstraZeneca

AstraZeneca is a global biopharmaceutical leader with a mission to push the boundaries of science to deliver life-changing medicines. The company has achieved significant commercial success with 16 blockbuster drugs and a robust pipeline of 197 projects, underpinned by a 'Growth Through Innovation' strategy focused on disease biology, next-generation therapeutics, predictive clinical success, and clinical innovation. AstraZeneca's strategic integration of data science, AI, and novel therapeutic modalities positions it to maintain its competitive edge and address complex healthcare challenges across its core therapeutic areas.

View full company profile